For the second year in a row, Columbia University received a top 5 spot in Inc. Magazine's list of Ignition Schools, institutions "shaping the next generation of entrepreneurs and business innovators."
XL Batteries is commercializing grid-scale flow batteries for the alternative energy grid, developed by Columbia's Dr. Colin Nuckolls.
Xscape Photonics, a startup founded by Columbia's Dr. Alex Gaeta, Dr. Michal Lipson, and Dr. Keren Bergman, announced with Tower Semiconductor the successful prototyping and validation of an on-chip, optically pumped, multi-wavelength laser source, built on Tower’s PH18 Silicon Photonics platform, intended for AI datacenter fabrics.
Still Bright, a startup co-founded by Columbia's Dr. Scott Banta and Dr. Alan West, raised an $18.7 million seed round led by Material Impact and Breakthrough Energy Ventures. Azolla Ventures, Fortescue, Impact Science Ventures, and SOSV also participated.
Columbia's Dr. Andrea Califano led the development of the model.
Nuvvon uses a sustainable and high-performance organic polymer-based cathode with outstanding fast charging performance and high commercial compatibility developed by Columbia's Dr. Colin Nuckolls.
Gilgamesh Pharmaceuticals, a startup co-founded by Columbia's Dr. Dalibor Sames, was mentioned in a story about Texas approving legislation to spend $50 million in state money researching ibogaine, a powerful psychedelic that has shown promise in treating opioid addiction, traumatic brain injury and depression. Last year Gilgamesh won a $14 million grant from The National Institute on Drug Abuse (NIDA) to study an ibogaine analogue that the company said offered the same benefits without the cardiac risks of plant-derived ibogaine.
MBF Bioscience announced the commercial launch of SLICE, a revolutionary light sheet microscope that represents a paradigm shift in advanced imaging technology, invented by Columbia's Dr. Raju Tomer.
Explore highlights, milestones, and what's ahead for L2M.
Columbia University will support BATWorks through its engagement with Columbia Technology Ventures and the ClimateTech Expertise Network.
Scientists led by Dr. Samuel Sternberg at Columbia University have improved upon a natural system called CRISPR-associated transposase, or CAST. It combines elements of the fabled gene editor with enzymes known as transposases that move so-called ‘jumping genes’ in and out of the genome.